CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Urinary Prostaglandin F2α Is Generated from the Isoprostane Pathway and Not the Cyclooxygenase in Humans

Open access

Abstract

Prostaglandins (PGs) derived from the enzymatic oxidation of arachidonic acid by the cyclooxygenases (COXs) are potent lipid mediators involved in human physiology and pathophysiology. Structurally similar compounds, the isoprostanes (IsoPs), are generated from the free radical-catalyzed oxidation of arachidonic acid independent of COX. IsoPs exhibit significant bioactivity and play a role in the pathogenesis of diseases associated with oxidant injury. As one of the major PGs, prostaglandin F(2alpha) (PGF(2alpha)) is present in human urine in significant concentrations and is presumed to be derived from COX activity. We determined, however, that levels of putative PGF(2alpha) in urine cannot be suppressed by nonsteroidal anti-inflammatory agents, suggesting that it is generated via another mechanism(s). An important difference between COX-derived PGF(2alpha) and the IsoPs is that the former is an optically pure compound, whereas IsoPs are racemic. Utilizing a rodent model of oxidative stress, we now show that significant amounts of compounds identical in all respects to PGF(2alpha) and its enantiomer, ent-PGF(2alpha), are formed in equal amounts esterified in tissue phospholipids, suggesting that these compounds are derived via the IsoP pathway. Further, employing liquid chromatography/mass spectrometry, the vast majority of putative PGF(2alpha) in human urine is derived from the free radical-initiated peroxidation of arachidonate independent of COX and is composed of PGF(2alpha) and its enantiomer, although the latter compound is approximately 2-fold more abundant. Thus, quantification of urinary PGF(2alpha) actually reflects oxidative stress status as opposed to COX activity. Indeed, levels of this compound are elevated in urine from cigarette smokers and in humans with hypercholesterolemia, two conditions associated with oxidant stress. The elucidation that urinary PGF(2alpha) in humans is derived from the IsoP pathway has implications regarding PG formation and inhibition in vivo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m608975200

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Free radical-induced oxidation of arachidonic acid forms four series of F 2 -IsoPs. A , mechanism of formation of F 2 -IsoPs from the oxidation of arachidonic acid. B , chemical structures of the four F 2 -IsoP regioisomers.
FIGURE 1 Free radical-induced oxidation of arachidonic acid forms four series of F 2 -IsoPs. A , mechanism of formation of F 2 -IsoPs from the oxidation of arachidonic acid. B , chemical structures of the four F 2 -IsoP regioisomers.CC-BY · From the PDF
FIGURE2 LC-MSanalysisofF2-IsoPsderivedfromSAPCoxidation in vitro ( A-C ) and from the oxidation of rat liver phospholipids in vivo ( D and E ). A , SRM MS spectra of F 2 -IsoP-free acids generated in vitro by ESI-MS (intensity was normalized to 15-series). F 2 -IsoPs 5-series , m / z 353 to 115 at 30 eV; 12-series , m / z 353 to 151 at 30eV; 8-series , m / z 353 to 127; 15-series , m / z 353 to 193; PGF2 𝛂 -d 4 , m / z 357to197at30eV. B , SRMMSspectraofthepeakthatco-elutes with PGF 2 𝛂 analyzed by normal phase LC-APCI-MS. C , SRM MS spectra of the samepeakasin panelB analyzedbyLC-APCI-MSusingachiralcolumn. D , SRMMS spectra of F 2 -IsoP-free acids generated in vivo by ESI-MS (intensity was normalized to 15-series). E , SRM MS spectra of the peak co-eluting with PGF 2 𝛂 analyzed by LC-APCI-MS using a chiral column. AA indicates the area integration.
FIGURE2 LC-MSanalysisofF2-IsoPsderivedfromSAPCoxidation in vitro ( A-C ) and from the oxidation of rat liver phospholipids in vivo ( D and E ). A , SRM MS spectra of F 2 -IsoP-free acids generated in vitro by ESI-MS (intensity was normalized to 15-series). F 2 -IsoPs 5-series , m / z 353 to 115 at 30 eV; 12-series , m / z 353 to 151 at 30eV; 8-series , m / z 353 to 127; 15-series , m / z 353 to 193; PGF2 𝛂 -d 4 , m / z 357to197at30eV. B , SRMMSspectraofthepeakthatco-elutes with PGF 2 𝛂 analyzed by normal phase LC-APCI-MS. C , SRM MS spectra of the samepeakasin panelB analyzedbyLC-APCI-MSusingachiralcolumn. D , SRMMS spectra of F 2 -IsoP-free acids generated in vivo by ESI-MS (intensity was normalized to 15-series). E , SRM MS spectra of the peak co-eluting with PGF 2 𝛂 analyzed by LC-APCI-MS using a chiral column. AA indicates the area integration.CC-BY · From the PDF
FIGURE 3 LC-MS analysis of F 2 -IsoPs from a urine sample of a healthy subject. A , SRM MS spectra of F2 -IsoP-free acid by ESI-MS (intensity was normalized to 5-series). B , SRM MS spectra of the putative PGF 2 𝛂 analyzed by normal phase LC-APCI-MS. C , SRM MS spectra of the same peak as in Fig. 4 B analyzed by LCAPCI-MS using a chiral column. AA indicates the area integration. The other experimental conditions are the same as in Fig. 2. D , CID spectra of endogenous ent -PGF2 𝛂 and PGF2 𝛂 , m / z 353.2 at 25 eV.
FIGURE 3 LC-MS analysis of F 2 -IsoPs from a urine sample of a healthy subject. A , SRM MS spectra of F2 -IsoP-free acid by ESI-MS (intensity was normalized to 5-series). B , SRM MS spectra of the putative PGF 2 𝛂 analyzed by normal phase LC-APCI-MS. C , SRM MS spectra of the same peak as in Fig. 4 B analyzed by LCAPCI-MS using a chiral column. AA indicates the area integration. The other experimental conditions are the same as in Fig. 2. D , CID spectra of endogenous ent -PGF2 𝛂 and PGF2 𝛂 , m / z 353.2 at 25 eV.CC-BY · From the PDF
FIGURE 4 Analysis of putative PGF 2 𝛂 in human urine after ibuprofen and LPS treatment by LC-MS. A , levels of PGF 2 𝛂 + entPGF2 𝛂 (ng/mg of creatinine ( Cr )) in human urine treated with ibuprofen. B , ratio of PGF 2 𝛂 / ent -PGF2 𝛂 . C , levels of PGF 2 𝛂 + entPGF2 𝛂 (ng/mg of creatinine) in human urine treated with LPS. D , ratio of PGF 2 𝛂 / ent -PGF2 𝛂 . Bars are mean ± S.E. (*, p < 0.05 with respect to the control).
FIGURE 4 Analysis of putative PGF 2 𝛂 in human urine after ibuprofen and LPS treatment by LC-MS. A , levels of PGF 2 𝛂 + entPGF2 𝛂 (ng/mg of creatinine ( Cr )) in human urine treated with ibuprofen. B , ratio of PGF 2 𝛂 / ent -PGF2 𝛂 . C , levels of PGF 2 𝛂 + entPGF2 𝛂 (ng/mg of creatinine) in human urine treated with LPS. D , ratio of PGF 2 𝛂 / ent -PGF2 𝛂 . Bars are mean ± S.E. (*, p < 0.05 with respect to the control).CC-BY · From the PDF
FIGURE 5 Analysis of putative PGF 2 𝛂 in human urine of patients with hypercholesterolemia and cigarette smokers analyzed by LC-MS methods. A , levels of PGF 2 𝛂 + entPGF2 𝛂 (ng/mg of creatinine) in human urine of hypercholesterolemia patients. B , ratio of PGF 2 𝛂 / entPGF2 𝛂 in human urine of hypercholesterolemia patients. C , levels of PGF 2 𝛂 + entPGF2 𝛂 (ng/mg of creatinine ( Cr )) in human urine of cigarette smokers ( n = 4). D , ratio of PGF 2 𝛂 / entPGF2 𝛂 ( n = 4). Bars are mean ± S.E. (*, p < 0.05; ***, p < 0.001 with respect to the control).
FIGURE 5 Analysis of putative PGF 2 𝛂 in human urine of patients with hypercholesterolemia and cigarette smokers analyzed by LC-MS methods. A , levels of PGF 2 𝛂 + entPGF2 𝛂 (ng/mg of creatinine) in human urine of hypercholesterolemia patients. B , ratio of PGF 2 𝛂 / entPGF2 𝛂 in human urine of hypercholesterolemia patients. C , levels of PGF 2 𝛂 + entPGF2 𝛂 (ng/mg of creatinine ( Cr )) in human urine of cigarette smokers ( n = 4). D , ratio of PGF 2 𝛂 / entPGF2 𝛂 ( n = 4). Bars are mean ± S.E. (*, p < 0.05; ***, p < 0.001 with respect to the control).CC-BY · From the PDF
FIGURE 6 Identification of eight diastereomers of 15-series F2-IsoPs by ESI-MS. A , representative SRM spectrum of 15-series F 2 -IsoP-free acid derived from 15-hydroperoxyeicosatetraenoic acid oxidation at 37 °C analyzed by reverse phase LC-ESI-MS. SRM, m / z 353 to 193 at 30 eV; PGF 2 𝛂 -d 4 , m / z 357 to 197 at 30 eV. B , chemical structure of the eight diastereomers of 15-series F 2 -IsoPs.
FIGURE 6 Identification of eight diastereomers of 15-series F2-IsoPs by ESI-MS. A , representative SRM spectrum of 15-series F 2 -IsoP-free acid derived from 15-hydroperoxyeicosatetraenoic acid oxidation at 37 °C analyzed by reverse phase LC-ESI-MS. SRM, m / z 353 to 193 at 30 eV; PGF 2 𝛂 -d 4 , m / z 357 to 197 at 30 eV. B , chemical structure of the eight diastereomers of 15-series F 2 -IsoPs.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 82

Metadata

Authors
Yin, H., Gao, L., Tai, H.-H., Murphey, L. J., Porter, N. A., & Morrow, J. D.
Affiliations
  • Vanderbilt University (US)
  • University of Kentucky (US)
Corresponding author
Morrow, Jason D.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2007-01
Volume
282
Issue
1
Pages
329-336
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2083913738
Cited by
82
References
39
Citations by year
2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 2 · 2016: 7 · 2015: 4 · 2014: 3 · 2013: 6 · 2012: 2
FWCI
3.76
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (ES00267, ES000267, GM 15431, CA 77839)
  • National Heart, Lung, and Blood Institute (HL-17921)
  • National Cancer Institute (CA77839, P01CA077839)
  • National Institute of General Medical Sciences (GM 15431)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 48831, R01DK048831)
  • National Institute of Environmental Health Sciences (P30ES000267, ES00267)
  • National Center for Research Resources (RR00095)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
isoprostanes, arachidonic acid oxidation, oxidative stress biomarkers, cigarette smoking, hypercholesterolemia, nonsteroidal anti-inflammatory drugs, enantiomeric ratio
MeSH terms
Animals, Female, Free Radicals, Humans, Lipids, Liver, Male, Oxygen, Phospholipids, Prostaglandin-Endoperoxide Synthases, Smoking, Dinoprost, Oxidative Stress, Isoprostanes, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Urinary Prostaglandin F2α Is Generated from the Isoprostane Pathway and Not the Cyclooxygenase in Humans. https://app.cochat.ai/papers/10.1074/jbc.m608975200
The paper
Yin, H., Gao, L., Tai, H.-H., Murphey, L. J., Porter, N. A., & Morrow, J. D. (2007). Urinary Prostaglandin F2α Is Generated from the Isoprostane Pathway and Not the Cyclooxygenase in Humans. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m608975200

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.